MHRP has been selected as a Clinical Trials Unit with four clinical research sites that will receive funding from NIAID to continue HIV vaccine and therapeutics research.
Department of Defense Assistant Secretary for Health, Dr. Jonathan Woodson, recently visited MHRP’s site in Nigeria, the Walter Reed Program-Nigeria (WRP-N).
Launched in 2003, the President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest effort by any nation to combat a single disease. PEPFAR, which began as an emergency response to AIDS in low-resource settings, is now focused on advancing the susta
In a new study published October 24 in the journal Cell, a scientific team has shown that bioinformatically optimized HIV vaccine antigens known as “mosaic” antigens might be useful in the design of a global HIV vaccine.
